TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension January 2, 1981
TCL Archive DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements November 23, 1979